AbCellera Biologics
ABCL
ABCL
114 hedge funds and large institutions have $1.99B invested in AbCellera Biologics in 2021 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 50 increasing their positions, 8 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+28
Holders Change %
+32.56%
% of All Funds
1.99%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
48
Increased
50
Reduced
8
Closed
20
Calls
$32.1M
Puts
$22.5M
Net Calls
+$9.59M
Net Calls Change
+$8.66M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AWE
126
Avidian Wealth Enterprises
Houston,
Texas
| – | -$441K | -13,000 | Closed |
|
127
Walleye Capital
New York
| – | -$360 | -10,593 | Closed |
|
|
CCM
128
CAAS Capital Management
New York
| – | -$340K | -10,000 | Closed |
|
|
PA
129
Paragon Advisors
College Station,
Texas
| – | -$300K | -8,840 | Closed |
|
|
LFM
130
Lumina Fund Management
New York
| – | -$102K | -3,000 | Closed |
|
131
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$81K | -2,395 | Closed |
|
|
FIA
132
FNY Investment Advisers
New York
| – | -$20K | -602 | Closed |
|
|
QT
133
Quantbot Technologies
New York
| – | -$14K | -435 | Closed |
|
|
SFS
134
Sowell Financial Services
North Little Rock,
Arkansas
| – | -$5K | -166 | Closed |
|